On this page
What should a nonprescription label comprehension report demonstrate?
Show how consumers understood the exact tested label against prespecified communication objectives and analysis rules. Link each objective to its question, verbatim responses, coding, denominator and statistical result. Explain literacy, missing data, deviations and version differences. Comprehension does not establish correct actual use, and a high observed percentage alone does not prove that the study met its success criterion.
Before you begin
Studies of consumer understanding of nonprescription drug labeling. Comprehension, self-selection and actual-use behavior are distinct questions; a comprehension result alone does not establish correct product use.
What you will prepare: A report that makes the tested label version, study conduct, quantitative results and qualitative interpretation reproducible.
Identify exactly what was tested
Collect the protocol and amendments, tested label artwork, interview instrument, recruitment materials, coding rules and analysis plan. Record which label version each participant saw. Map each communication objective to its question, response rule and success criterion. Criteria established after seeing results must be identified as post hoc, not presented as prespecified success.
Describe who participated and how answers were obtained
Explain recruitment, screening, exclusions, enrollment, completion and relevant demographics, including literacy assessment. Describe whether questions were self-administered or asked by trained interviewers, how prompts were standardized and whether participants could consult the label. Preserve verbatim answers and explain coding changes. Leading questions or coaching can change what the study measured; report deviations and their possible effect rather than deleting them from the narrative.
Pair comprehension estimates with the underlying answers
Present results by objective and relevant subgroup with denominators and missing responses visible. Explain the prespecified statistical approach without inventing a universal passing percentage. Compare coded correct answers with the underlying words: an apparently correct selection can mask a misunderstanding. Distinguish label improvements suggested by the study from proven improvements; revised wording has not been tested merely because it seems clearer.
Fictional review exercise
A participant selects the correct option but explains an unsafe interpretation in the verbatim response. Flag the mismatch and apply the documented coding/interpretation procedure; do not erase it to improve the rate. If half the interviews used revised artwork, reconcile version-specific populations before pooling. If the tested label cannot be recovered, identify that limitation explicitly and seek the actual study artifact before claiming the report evaluates the submission label.
Make the path from label message to study conclusion auditable
A good report allows the reviewer to reconstruct the result without guessing what was asked or how answers were scored. Use one row for each communication objective, preserving the relationship to the tested artwork.
| Field | What to report | Review question |
|---|---|---|
| Objective | Label message and primary or secondary status | Was its importance and status specified before results were known? |
| Question | Exact wording, order and any standardized probe | Did it test understanding without teaching the answer? |
| Response | Verbatim answer and applicable response category | Does a selected option agree with the participant's explanation? |
| Coding | Prespecified rule and documented adjudication | Were post-hoc changes disclosed and their effect assessed? |
| Analysis | Population, denominator, missing-data handling and confidence interval | Does the conclusion use the planned method? |
| Interpretation | Overall and relevant subgroup results, errors and limitations | What was understood, what was misunderstood and what remains uncertain? |
The August 2010 guidance recommends a confidence-interval approach to primary-endpoint success. Its example requires the lower bound of the two-sided 95% interval, or corresponding one-sided 97.5% interval, to be above the predefined target. It does not prescribe one universal passing percentage for every message. Primary targets should reflect clinical significance. The guidance does not require prespecified target comprehension levels for secondary communication objectives.
Fictional statistical exercise: a protocol prespecifies an 85% primary target and a Wilson two-sided 95% interval. Ninety of 100 participants answer correctly. The observed rate is 90%, but the interval is approximately 82.6%–94.5%; its lower bound does not exceed 85%. The report cannot claim success from the point estimate alone. These numbers illustrate interpretation, not a recommended target or mandatory interval method. If several endpoints are co-primary, assess each under the prespecified plan rather than averaging a failure into an overall passing rate.
Explain the literacy assessment rather than using education level as a substitute. The guidance specifically distinguishes the two. Describe recruitment, the chosen validated assessment and the relevant subgroup results. A strong overall result can coexist with a meaningful misunderstanding in a subgroup, and that limitation belongs in the report.
Participants may consult the label under the guidance's study-conduct recommendations, but excessive prompting or coaching can change what is measured. Preserve the actual instructions and deviations. For closed-ended questions, use the planned open-ended probing and coding approach to distinguish understanding from a lucky selection. Do not recode an unsafe explanation as correct merely because the selected option was correct.
If the label changes during the study, identify who saw which version and assess whether pooling is justified. A proposed improvement after the study is an untested change until supported by appropriate evidence. Link the tested artwork to the carton/container record and explain differences from the current draft labeling.
Your preparation checklist
0/3 checkedUse this to track your review in this visit. Checks are not saved and do not establish regulatory compliance.
Frequently asked questions
Does a comprehension rate above the target automatically mean the study passed?
No. Apply the prespecified success criterion, including the confidence-interval approach described by FDA. In its single-primary-endpoint example, the lower confidence bound must exceed the predefined target. A favorable point estimate can still fail that criterion, and a post-hoc target should not be described as prespecified.
Can education level substitute for literacy assessment?
FDA’s guidance says education level is not a reliable substitute for literacy testing. Describe the validated assessment used, recruitment and the literacy distribution of participants. Report the relevant subgroup findings and limitations rather than assuming a college or school category proves how participants understood the label.
Does a correct multiple-choice answer prove the participant understood the warning?
Not necessarily. The guidance discusses open-ended probing to distinguish understanding from chance selection and calls for verbatim responses and prespecified coding. Review the participant’s explanation using the planned procedure, and disclose post-hoc adjudication rather than discarding a contradictory explanation to improve the rate.
Does a successful comprehension study prove that consumers will use the product correctly?
No. Understanding labeling, deciding whether a product is appropriate for oneself and actual use are different questions. FDA’s guidance places behavior outside the label-comprehension study scope. Limit the report’s conclusion to what the design measured, and do not treat revised untested labeling as already validated.
Sources and revisions
Requirements, source recommendations and editorial preparation advice have different roles. Review the scope and revision of the source you use.
Guidance
FDA: Label Comprehension Studies for Nonprescription Drug Products ↗August 2010 final guidance; sections III–V. Nonprescription scope, not proof of actual-use behavior. Checked September 22, 2026.
Technical specification · placement only
FDA eCTD v4.0 comprehensive hierarchy ↗Version 2.2, February 2025. Section 1.14.1.4. A heading identifies placement, not mandatory applicability.